Promus PREMIER™ H7493952816400Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of Promus PREMIER (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08714729844754), received between Nov 18, 2016 and Sep 5, 2017 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Dislodged or Dislocated2
- Bent1
- Failure to Advance1
Patient problems
- No Consequences Or Impact To Patient4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 5, 2017Failure to Advance; Failure to Advance
REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 24-AUG-2017. IT WAS REPORTED THAT DIFFICULTY CROSSING THE LESION OCCURRED. A 4.00X16MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE TARGET LESION. HOWEVER, IT FAILED TO CROSS THE LESION. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE. HOWEVER, RETURNED DEVICE ANALYSIS REVEALED STENT DETACHED/SEPARATED AND STENT DAMAGED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6842830 ↗MalfunctionMar 7, 2017Bent; Bent
SAME CASE AS MDR ID: 2134265-2017-01671 IT WAS REPORTED THAT THE STENT DAMAGE OCCURRED. THE TARGET LESION WAS LOCATED IN THE RIGHT CORONARY ARTERY (RCA). A 4.00X32MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, DURING THE PROCEDURE, THE STENT BUNCHED UP IN THE MIDDLE OF THE BALLOON AND SLID A COUPLE OF MILLIMETERS OFF THE END OF THE BALLOON. THE PROXIMAL END OF THE STENT WAS HALF WAY DOWN THE BALLOON. TO PREVENT THE STENT TO BE DISLODGED FROM THE BALLOON, THE PHYSICIAN DEPLOYED THE STENT TO WHERE IT WAS. THE PHYSICIAN THEN DILATED THE FIRST STENT AFTER IT WAS DEPLOYED. THE PHYSICIAN ADVANCED A 4.00X16MM PROMUS PREMIER¿ DRUG-ELUTING STENT BUT THERE WAS DIFFICULTY PASSING THROUGH THE FIRST DEPLOYED STENT. WHILE PULLING THE SECOND STENT OUT, IT HUNG UP ON THE FIRST STENT AND THE FIRST STENT HUNG UP ON THE GUIDE. THE SECOND STENT HAD A BURR IN THE MIDDLE OF THE STENT. A NON-BSC GUIDE EXTENSION CATHETER WAS THEN ADVANCED AND ANOTHER PROMUS STENT WAS DELIVERED WHICH COMPLETED THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6385244 ↗MalfunctionJan 18, 2017Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGMENT OCCURRED. THE TARGET LESION WAS LOCATED IN A CORONARY ARTERY. A 4.00X16MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, THE STENT SEPARATED FROM THE DELIVERY SYSTEM INSIDE THE GUIDE CATHETER. THE DELIVERY SYSTEM WAS PULLED OUT AND THEY WERE ABLE TO GET THE STENT OUT AS WELL. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6262182 ↗MalfunctionNov 18, 2016Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. THE TARGET LESION WAS LOCATED IN THE PROXIMAL CIRCUMFLEX ARTERY. A 4.00X16MM PROMUS PREMIER¿ DRUG-ELUTING STENT WAS ADVANCED TO TREAT THE LESION. HOWEVER, WHILE ATTEMPTING TO IMPLANT THE DEVICE, THE STENT CAME OFF FROM THE STENT DELIVERY SYSTEM (SDS) IN THE LEFT MAIN (LM) ARTERY AND WAS FOUND IN THE TUOHY OF THE NON-BSC GUIDE CATHETER. THE DEVICE WAS COMPLETELY REMOVED FROM THE PATIENT'S BODY AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6112800 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page